Literature DB >> 26773626

Imaging techniques in leprosy clinics.

Suman Jain1, Leo H Visser2, Sujai Suneetha3.   

Abstract

Leprosy is the most common treatable peripheral nerve disorder worldwide, with periods of acute neuritis leading to functional impairment of limbs and stigmatizing deformities. The nerve involvement in leprosy reactions, if recognized early and promptly treated with steroids and nerve release surgery, can be reversible. Currently, the nerve assessment in leprosy relies mainly on clinical assessment and nerve conduction studies. High-resolution ultrasonography (HRUS) of peripheral nerves is finding wider application in the differential diagnosis of peripheral neuropathy. HRUS provides a noninvasive tool that gives information on location and degree of nerve enlargement, nerve morphologic alterations, echo texture, fascicular pattern, and vascularity of the nerve, which mirrors the histologic changes. HRUS is amenable to studying structural changes in nerve sites that cannot be biopsied for histopathologic examination and is more cost effective than magnetic resonance imaging. So far other there are only five studies available on the sonographic findings in leprosy. These findings are reviewed and the technique of HRUS is described in this paper, with a recommendation of a standard protocol and proforma.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26773626     DOI: 10.1016/j.clindermatol.2015.10.014

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  2 in total

1.  Nerve abscess in pure neural leprosy mistaken for peripheral nerve sheath tumour with disastrous consequence: what can we learn?

Authors:  Vishal Gupta; Tanvi Dev; Chandan J Das; Neena Khanna
Journal:  BMJ Case Rep       Date:  2017-12-05

2.  Coexistence of Nerve Enlargement and Neuratrophy Detected by Ultrasonography in Leprosy Patients.

Authors:  Xiaohua Chen; Liangfu Zhang; Meiying Huang; Xiuli Zhai; Yan Wen; Chunzhi Pan
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.